Recent recorded grades — Spring 2024: 3.81 GPA, 90.5% A/AB (n=21 letter grades); Fall 2024: 3.75 GPA, 86.4% A/AB (n=22 letter grades); Spring 2025: 3.88 GPA, 91.7% A/AB (n=12 letter grades).
Recent recorded grades — Spring 2024: 3.63 GPA, 80.0% A/AB (n=15 letter grades); Fall 2024: 3.58 GPA, 83.3% A/AB (n=24 letter grades); Spring 2025: 3.79 GPA, 83.3% A/AB (n=12 letter grades).
This course applies and analyzes professional scientific communication in biotechnology, focusing on designing written and oral documents like reports and presentations for complex, data-rich content.
Recent recorded grades — Spring 2024: 3.94 GPA, 93.8% A/AB (n=16 letter grades); Fall 2024: 4.00 GPA, 100.0% A/AB (n=11 letter grades); Spring 2025: 3.88 GPA, 94.1% A/AB (n=17 letter grades).
Covers biotechnological product development using biological and chemical methods, analyzing techniques for characterizing products and evaluating quality, safety, and the pipeline from conception to market.
Recent recorded grades — Spring 2025: 3.26 GPA, 73.7% A/AB (n=19 letter grades); Fall 2025: 3.67 GPA, 66.7% A/AB (n=6 letter grades); Spring 2026: 3.92 GPA, 100.0% A/AB (n=6 letter grades).
Covers descriptive and inferential statistics applied to biotechnology, focusing on experimental design, quantitative data analysis, and bioinformatic evaluation of molecular data sets.
Recent recorded grades — Spring 2025: 3.79 GPA, 100.0% A/AB (n=7 letter grades); Fall 2025: 3.86 GPA, 100.0% A/AB (n=7 letter grades); Spring 2026: 4.00 GPA, 100.0% A/AB (n=9 letter grades).
Examines regulatory environments in risk-based assessment of biotechnological developments in industry, agriculture, and probiotics, highlighting stakeholder roles in oversight and policy through case studies.
Recent recorded grades — Spring 2024: 3.43 GPA, 85.7% A/AB (n=7 letter grades); Spring 2025: 3.75 GPA, 83.3% A/AB (n=12 letter grades); Spring 2026: 3.58 GPA, 83.3% A/AB (n=12 letter grades).
Global Operations and Supply Chain Management focuses on the strategic importance of operations and supply chains to business performance in biotechnology.
Recent recorded grades — Spring 2024: 3.73 GPA, 100.0% A/AB (n=13 letter grades); Spring 2025: 3.72 GPA, 77.8% A/AB (n=9 letter grades); Spring 2026: 3.58 GPA, 83.3% A/AB (n=6 letter grades).
Covers quality and project management in biotechnology from R&D to market, including IQ/OQ/PQ validation, project phases, schedule/time tools, and quality assurance.
Recent recorded grades — Spring 2023: 4.00 GPA, 100.0% A/AB (n=10 letter grades); Spring 2025: 3.77 GPA, 100.0% A/AB (n=11 letter grades); Spring 2026: 3.67 GPA, 88.9% A/AB (n=9 letter grades).
Tools for Data Analysis uses bioinformatics tools and computational methods for hands-on analysis of large datasets like genomic and proteomic data to solve biotechnology problems.
Recent recorded grades — Spring 2024: 3.89 GPA, 100.0% A/AB (n=9 letter grades); Spring 2025: 3.90 GPA, 100.0% A/AB (n=21 letter grades); Spring 2026: 3.90 GPA, 100.0% A/AB (n=15 letter grades).
Bioinformatic Inquiry advances competencies for analyzing biological data by balancing existing software with de novo development using advanced Python, R, algorithmics, machine learning, and simulations.
PRE-CAPSTONE prepares students for an applied self-directed capstone by addressing problem identification, research, and project formulation, culminating in an oral and written proposal with a project schedule.
Recent recorded grades — Spring 2025: 4.00 GPA, 100.0% A/AB (n=13 letter grades); Fall 2025: 4.00 GPA, 100.0% A/AB (n=15 letter grades); Spring 2026: 3.86 GPA, 100.0% A/AB (n=11 letter grades).
Capstone course requiring a project in quality assurance, business management, or R&D, culminating in a substantive report, executive summary, and professional networking.
Recent recorded grades — Spring 2025: 4.00 GPA, 100.0% A/AB (n=8 letter grades); Fall 2025: 4.00 GPA, 100.0% A/AB (n=10 letter grades); Spring 2026: 4.00 GPA, 100.0% A/AB (n=19 letter grades).
Survey of techniques in the biotechnology industry for complying with quality and regulatory requirements from professional and governmental agencies to develop, manufacture, and commercialize products safely.
Explores six biotechnology product development specialties including regulatory, quality, and clinical aspects, while focusing on leadership and implementation plans to bring products to market.
Molecular Technologies II: Biomanufacturing covers nucleic acid/protein analysis, purification strategies, and batch record development for biotech manufacturing.
Professional Development and Effective Management focuses on management techniques, career success, leading biotech teams, and developing resumes and interviewing skills.
Advanced course investigating global biotechnology topics like stem cells, metagenomics, and biomanufacturing, focusing on scientific, ethical, and regulatory standards.
Explores how biotech firms gain competitive advantage using business tools and critiques leadership decision-making under uncertainty to develop company-wide strategy.
Students identify a global biotechnology problem, develop a novel technical solution, analyze it from business, regulatory, and IP perspectives, and write a final capstone thesis.